G. Ruiter

1740P Track and treat in NSCLC (TATIN) - ctDNA guided treatment of early resistance to second-line osimertinib treatment in patients with EGFR mutation positive (EGFRm) NSCLC

Jan van der Wel, P. Baas, E. Wall, 2021, Annals of Oncology.

Handbook Twitter for Research, 2015 / 2016

Ritesh M. Shah, Johanna I. Honorato, Nelleke Oostdijk, 2016 .